
2025 Amendments to Medical and Pharmaceutical Marketing Practices: Valuation of Free Samples & Annual Disclosures
DoP revises the UCPMP’24 and UCMPMD’24 to simplify compliance procedures and reduce the administrative burden on pharmaceutical and medical device companies, particularly in relation to the disclosure of marketing expenditure involving free samples and educational programs.
Continue reading